Biomarkers of necrotizing enterocolitis: a review of literature

References

• Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005;115(3):696–703.
   PubMed Web of Science ®Google Scholar
• Fanaroff AA, Hack M, Walsh MC, et al. The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol. 2003;27(4):281–287.
   PubMed Web of Science ®Google Scholar
• Holman RC, Stoll BJ, Curns AT, et al. Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol. 2006;20(6):498–506.
   PubMed Web of Science ®Google Scholar
• Sia KL, Gold L, Jacobs S, et al. Hospital DRG costing and health services use of very pre-term infants from the Proprems Neuro study across 10 hospitals in Australia and New Zealand. Value Health. 2014;17(7):A518–A519.
   PubMed Web of Science ®Google Scholar
• Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics. 2001;107(1):E1.
   PubMed Web of Science ®Google Scholar
• Obladen M. Necrotizing enterocolitis −150 years of fruitless search for the cause. Neonatology. 2009;96(4):203–210.
   PubMed Web of Science ®Google Scholar
• Sharma R, Hudak ML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol. 2013;40(1):27–51.
   PubMed Web of Science ®Google Scholar
• Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368(9543):1271–1283.
   PubMed Web of Science ®Google Scholar
• Patel RM, Denning PW. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? Clin Perinatol. 2013;40(1):11–25.
   PubMed Web of Science ®Google Scholar
• Sharma D, Shastri S. Lactoferrin and neonatology – role in neonatal sepsis and necrotizing enterocolitis: present, past and future. J Matern Fetal Neonatal Med. 2016;29(5):763–770.
   PubMed Web of Science ®Google Scholar
• Sharma D, Shastri S, Sharma P. Role of lactoferrin in neonatal care: a systematic review. J Matern Fetal Neonatal Med. 2017;30(16):1920–1932.
   PubMed Web of Science ®Google Scholar
• Shah P, Shah V. Arginine supplementation for prevention of necrotising enterocolitis in preterm neonates. Cochrane Database Syst Rev. 2007;3:CD004339.
   Google Scholar
• Moe-Byrne T, Brown JVE, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm neonates. Cochrane Database Syst Rev. 2016;4:CD001457.
   PubMedGoogle Scholar
• Ramani M, Ambalavanan N. Feeding practices and necrotizing enterocolitis. Clin Perinatol. 2013;40(1):1–10.
   PubMed Web of Science ®Google Scholar
• Sharma D, Farahbakhsh N, Shastri S, et al. Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med. 2017:1–14.
   Web of Science ®Google Scholar
• Cheu HW, Brown DR, Rowe MI. Breath hydrogen excretion as a screening test for the early diagnosis of necrotizing enterocolitis. Am J Dis Child. 1989;143(2):156–159.
   PubMedGoogle Scholar
• Garstin WI, Boston VE. Sequential assay of expired breath hydrogen as a means of predicting necrotizing enterocolitis in susceptible infants. J Pediatr Surg. 1987;22(3):208–210.
   PubMed Web of Science ®Google Scholar
• Lieberman JM, Sacchettini J, Marks C, et al. Human intestinal fatty acid binding protein: Report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997;121(3):335–342.
   PubMed Web of Science ®Google Scholar
• Startinig B, Mutz I. Determination of hydrogen in expiratory air of premature neonates in suspected necrotizing enterocolitis. Monatsschr Kinderheilkd. 1992;140:296–299.
   PubMedGoogle Scholar
• Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352(1–2):15–35.
   PubMed Web of Science ®Google Scholar
• Relja B, Szermutzky M, Henrich D, et al. Intestinal-FABP and liver- FABP: novel markers for severe abdominal injury. Acad Emerg Med. 2010;17(7):729–735.
   PubMed Web of Science ®Google Scholar
• Cronk DR, Houseworth TP, Cuadrado DG, et al. Intestinal fatty acid binding protein (I–FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg. 2006;63(5):322–325.
   PubMedGoogle Scholar
• Derikx JP, Evennett NJ, Degraeuwe PL, et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotizing enterocolitis. Gut. 2007;56(10):1473–1475.
   PubMed Web of Science ®Google Scholar
• Gollin G, Marks WH. Elevation of circulating intestinal fatty acid binding protein in a luminal contents-initiated model of NEC. J Pediatr Surg. 1993;28(3):367–370; discussion 370
   PubMed Web of Science ®Google Scholar
• Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7.
   PubMed Web of Science ®Google Scholar
• Aydemir C, Dilli D, Oguz SS, et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev. 2011;87(10):659–661.
   PubMed Web of Science ®Google Scholar
• Edelson MB, Sonnino RE, Bagwell CE, et al. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg. 1999;34(10):1453–1457.
   PubMed Web of Science ®Google Scholar
• Briana DD, Liosi S, Gourgiotis D, et al. Cord blood intestinal fatty acid-binding protein (I–FABP) in full-term intrauterine growth restricted pregnancies. J Matern Fetal Neonatal Med. 2012;25(10):2062–2065.
   PubMed Web of Science ®Google Scholar
• Guthmann F, Börchers T, Wolfrum C, et al. Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem. 2002;239(1–2):227–234.
   PubMed Web of Science ®Google Scholar
• Evennett NJ, Hall NJ, Pierro A, et al. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg. 2010;45(4):735–740.
   PubMed Web of Science ®Google Scholar
• Schurink M, Kooi EM, Hulzebos CV, et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One. 2015;10(3):e0121336.
   PubMed Web of Science ®Google Scholar
• Heida FH, Hulscher JB, Schurink M, et al. Intestinal fatty acid-binding protein levels in Necrotizing Enterocolitis correlate with extent of necrotic bowel: results from a multicenter study. J Pediatr Surg. 2015;50(7):1115–1118.
   PubMed Web of Science ®Google Scholar
• Cheng S, Yu J, Zhou M, et al. Serologic intestinal-fatty acid binding protein in necrotizing enterocolitis diagnosis: a meta-analysis. BioMed Res Int. 2015;2015:156704.
   PubMed Web of Science ®Google Scholar
• Yang G, Wang Y, Jiang X. Diagnostic value of intestinal fatty-acid-binding protein in necrotizing enterocolitis: a systematic review and meta-analysis. Indian J Pediatr. 2016;83(12–13):1410–1419.
   PubMed Web of Science ®Google Scholar
• Dale I, Brandtzaeg P, Fagerhol MK, et al. Distribution of a new myelomoncytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol. 1985;84(1):24–34.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis. 2009;41(1):56–66.
   PubMedGoogle Scholar
• Røseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34(1):50–54.
   PubMed Web of Science ®Google Scholar
• Josefsson S, Bunn SK, Domellöf M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr. 2007;44(4):407–413.
   PubMed Web of Science ®Google Scholar
• Yang Q, Smith PB, Goldberg RN, et al. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology. 2008;94(4):267–271.
   PubMed Web of Science ®Google Scholar
• Zoppelli L, Güttel C, Bittrich HJ, et al. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology. 2012;102(1):68–74.
   PubMed Web of Science ®Google Scholar
• Aydemir O, Aydemir C, Sarikabadayi YU, et al. Fecal calprotectin levels are increased in infants with necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2012;25(11):2237–2241.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang X, Zhang J. Diagnostic value of fecal calprotectin in preterm infants with necrotizing enterocolitis. Clin Lab. 2016;62(5):863–869.
   PubMed Web of Science ®Google Scholar
• Yoon JM, Park JY, Ko KO, et al. Fecal calprotectin concentration in neonatal necrotizing enterocolitis. Korean J Pediatr. 2014;57(8):351–356.
   PubMedGoogle Scholar
• Albanna EA, Ahmed HS, Awad HA. Stool calprotectin in necrotizing enterocolitis. J Clin Neonatol. 2014;3(1):16–19.
   PubMedGoogle Scholar
• Reisinger KW, Van der Zee DC, Brouwers HA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg. 2012;47(9):1640–1645.
   PubMed Web of Science ®Google Scholar
• Tian YF, Li L, Mi HY, et al. Value of combined measurement of intestinal fatty acid-binding protein and fecal calprotectin in diagnosis of necrotizing enterocolitis in full-term neonates. Zhongguo Dang Dai Er Ke Za Zhi. 2016;18(11):1080–1083.
   PubMedGoogle Scholar
• Pergialiotis V, Konstantopoulos P, Karampetsou N, et al. Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature. Inflamm Res. 2016;65(11):847–852.
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Ren Z, et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 2008;216(2):183–192.
   PubMed Web of Science ®Google Scholar
• Däbritz J, Jenke A, Wirth S, et al. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr. 2012;161(6):1059–1064.
   PubMed Web of Science ®Google Scholar
• Bergmann KR, Liu SXL, Tian R, et al. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol. 2013;182(5):1595–1606.
   PubMed Web of Science ®Google Scholar
• Thuijls G, Derikx JP, van Wijck K, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg. 2010;251(6):1174–1180.
   PubMed Web of Science ®Google Scholar
• Blackwood BP, Wood DR, Yuan CY, et al. Urinary claudin-2 measurements as a predictor of necrotizing enterocolitis: a pilot study. J Neonatal Surg. 2015;4(4):43.
   PubMedGoogle Scholar
• Verklan MT, Padhye NS. Spectral analysis of heart rate variability: an emerging tool for assessing stability during transition to extrauterine life. J Obstet Gynecol Neonatal Nurs. 2004;33(2):256–265.
   PubMedGoogle Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043–1065.
   PubMed Web of Science ®Google Scholar
• Porges SW. Cardiac vagal tone: a physiological index of stress. Neurosci Biobehav Rev. 1995;19(2):225–233.
   PubMed Web of Science ®Google Scholar
• Doheny KK, Palmer C, Browning KN, et al. Diminished vagal tone is a predictive biomarker of necrotizing enterocolitis-risk in preterm infants. Neurogastroenterol Motil. 2014;26(6):832–840.
   PubMed Web of Science ®Google Scholar
• Sadler PJ, Tucker A, Viles JH. Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+. Eur J Biochem. 1994;220(1):193–200.
   PubMedGoogle Scholar
• Yakut I, Tayman C, Oztekin O, et al. Ischemia-modified albumin may be a novel marker for the diagnosis and follow-up of necrotizing enterocolitis. J Clin Lab Anal. 2014;28(3):170–177.
   PubMed Web of Science ®Google Scholar
• Duh G, Mouri N, Warburton D, et al. EGF regulates early embryonic mouse gut development in chemically defined organ culture. Pediatr Res. 2000;48(6):794–802.
   PubMed Web of Science ®Google Scholar
• Shin CE, Falcone RA Jr., Stuart L, et al. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg. 2000;35(2):173–176; discussion 177
   PubMed Web of Science ®Google Scholar
• Warner BB, Ryan AL, Seeger K, et al. Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr. 2007;150(4):358–363.
   PubMed Web of Science ®Google Scholar
• Wahab Mohamed WA, Aseeri AM. Cord blood epidermal growth factor as a possible predictor of necrotizing enterocolitis in very low birth weight infants. J Neonat Perinat Med. 2013;6(3):257–262.
   PubMedGoogle Scholar
• Gerber HP, Hillan KJ, Ryan AM, et al. VEGF is required for growth and survival in neonatal mice. Development. 1999;126(6):1149–1159.
   PubMed Web of Science ®Google Scholar
• Sabnis A, Carrasco R, Liu SX, et al. Intestinal vascular endothelial growth factor is decreased in necrotizing enterocolitis. Neonatology. 2015;107(3):191–198.
   PubMed Web of Science ®Google Scholar
• Thim L. Trefoil peptides: a new family of gastrointestinal molecules. Digestion. 1994;55(6):353–360.
   PubMed Web of Science ®Google Scholar
• Ng EW, Poon TC, Lam HS, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg. 2013;258(6):1111–1118.
   PubMed Web of Science ®Google Scholar
• Markel TA, Crisostomo PR, Wairiuko GM, et al. Cytokines in necrotizing enterocolitis. Shock. 2006;25(4):329–337.
   PubMed Web of Science ®Google Scholar
• Harris MC, Costarino AT Jr, Sullivan JS, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr. 1994;124(1):105–111.
   PubMed Web of Science ®Google Scholar
• Hunter CJ, Singamsetty VK, Chokshi NK, et al. Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J Infect Dis. 2008;198(4):586–593.
   PubMed Web of Science ®Google Scholar
• Morecroft JA, Spitz L, Hamilton PA, et al. Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr Suppl. 1994;396:18–20.
   PubMedGoogle Scholar
• Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro and counter inflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics. 1999;103(4 Pt 1):766–771.
   PubMed Web of Science ®Google Scholar
• Benkoe T, Reck C, Gleiss A, et al. Interleukin 8 correlates with intestinal involvement in surgically treated infants with necrotizing enterocolitis. J Pediatr Surg. 2012;47(8):1548–1554.
   PubMed Web of Science ®Google Scholar
• Benkoe T, Reck C, Pones M, et al. Interleukin-8 predicts 60-day mortality in premature infants with necrotizing enterocolitis. J Pediatr Surg. 2014;49(3):385–389.
   PubMed Web of Science ®Google Scholar
• Benkoe TM, Mechtler TP, Weninger M, et al. Serum levels of interleukin-8 and gut-associated biomarkers in diagnosing necrotizing enterocolitis in preterm infants. J Pediatr Surg. 2014;49(10):1446–1451.
   PubMed Web of Science ®Google Scholar
• Neunhoeffer F, Jansen H, Goelz R, et al. Combination of excessive weight gain and interleukin-8: a possible predictor of necrotising enterocolitis in neonates? Z Geburtshilfe Neonatol. 2015;219(5):221–225.
   PubMed Web of Science ®Google Scholar
• Garofalo R, Chheda S, Mei F, et al. Interleukin-10 in human milk. Pediatr Res. 1995;37(4 Pt 1):444–449.
   PubMed Web of Science ®Google Scholar
• Fituch CC, Palkowetz KH, Goldman AS, et al. Concentrations of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatr. 2004;93(11):1496–1500.
   PubMed Web of Science ®Google Scholar
• Benkoe T, Baumann S, Weninger M, et al. Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PLoS One. 2013;8(3):e58720.
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Kelly DR, Nicola T, et al. TGF-beta 2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology. 2011;140(1):242–253.
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Schelonka RL, Dimmitt RA, et al. Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res. 2014;76(1):100–108.
   PubMed Web of Science ®Google Scholar
• Pourcyrous M, Korones SB, Yang W, et al. C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics. 2005;116(5):1064–1069.
   PubMed Web of Science ®Google Scholar
• Van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004;4(10):620–630.
   PubMed Web of Science ®Google Scholar
• Turner D, Hammerman C, Rudensky B, et al. Low levels of procalcitonin during episodes of necrotizing enterocolitis. Dig Dis Sci. 2007;52(11):2972–2976.
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Ozkan H, Köksal N, et al. Comparison of the efficacy of serum amyloid A, C-reactive protein, and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants. J Pediatr Surg. 2011;46(8):1482–1489.
   PubMed Web of Science ®Google Scholar
• Camussi G, Tetta C, Baglioni C. The role of platelet-activating factor in inflammation. Clin Immunol Immunopathol. 1990;57(3):331–338.
   PubMedGoogle Scholar
• Rabinowitz SS, Dzakpasu P, Piecuch S, et al. Platelet-activating factor in infants at risk for necrotizing enterocolitis. J Pediatr. 2001;138(1):81–86.
   PubMed Web of Science ®Google Scholar
• Amer MD, Hedlund E, Rochester J, et al. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biol Neonate. 2004;85(3):159–166.
   PubMedGoogle Scholar
• Eckhardt ERM, Witta J, Zhong J, et al. Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis. BMC Gastroenterol. 2010;10:133.
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Ozkan H, Köksal N, et al. The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants. Pediatr Surg Int. 2010;26(8):835–841.
   PubMed Web of Science ®Google Scholar
• Eras Z, Oğuz S, Dizdar EA, et al. Serum amyloid-A levels in neonatal necrotizing enterocolitis. J Clin Lab Anal. 2011;25(4):233–237.
   PubMed Web of Science ®Google Scholar
• Reisinger KW, Kramer BW, Van der Zee DC, et al. Non-invasive serum amyloid A (SAA) measurement and plasma platelets for accurate prediction of surgical intervention in severe necrotizing enterocolitis (NEC). PLoS One. 2014;9(6):e90834.
   PubMedGoogle Scholar
• Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol. 2005;23:821–852.
   PubMed Web of Science ®Google Scholar
• Fleming SD, Mastellos D, Karpel-Massler G, et al. C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. Clin Immunol. 2003;108(3):263–273.
   PubMed Web of Science ®Google Scholar
• Tayman C, Tonbul A, Kahveci H, et al. C5a, a complement activation product, is a useful marker in predicting the severity of necrotizing enterocolitis. Tohoku J Exp Med. 2011;224(2):143–150.
   PubMed Web of Science ®Google Scholar
• Lim YP, Bendelja K, Opal SM, et al. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis. 2003;188(6):919–926.
   PubMed Web of Science ®Google Scholar
• Daveau M, Rouet P, Scotte M, et al. Human inter-alpha-inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins. Biochem J. 1993;292(Pt 2):485–492.
   PubMed Web of Science ®Google Scholar
• Chaaban H, Singh K, Huang J, et al. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis. J Pediatr. 2009;154(4):620–622.e1
   PubMed Web of Science ®Google Scholar
• Chaaban H, Shin M, Sirya E, et al. Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr. 2010;157(5):757–761.
   PubMed Web of Science ®Google Scholar
• Shah BA, Migliori A, Kurihara I, et al. Blood level of inter-alpha inhibitor proteins distinguishes necrotizing enterocolitis from spontaneous intestinal perforation. J Pediatr. 2017;180:135–140.e1
   PubMed Web of Science ®Google Scholar
• Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117(6):1901–1906.
   PubMed Web of Science ®Google Scholar
• Treszl A, Kocsis I, Szathmári M, et al. Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr. 2001;90(10):1182–1185.
   PubMed Web of Science ®Google Scholar
• Treszl A, Héninger E, Kálmán A, et al. Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg. 2003;38(9):1374–1378.
   PubMed Web of Science ®Google Scholar
• Prencipe G, Azzari C, Moriondo M, et al. Association between mannose-binding lectin gene polymorphisms and necrotizing enterocolitis in preterm infants. J Pediatr Gastroenterol Nutr. 2012;55(2):160–165.
   PubMed Web of Science ®Google Scholar
• Schlapbach LJ, Aebi C, Fisch U, et al. Higher cord blood levels of mannose-binding lectin-associated serine protease-2 in infants with necrotising enterocolitis. Pediatr Res. 2008;64(5):562–566.
   PubMed Web of Science ®Google Scholar
• Kim SY, Koo JE, Seo YJ, et al. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2. Br J Pharmacol. 2013;168(8):1933–1945.
   PubMed Web of Science ®Google Scholar
• Shibata T, Motoi Y, Tanimura N, et al. Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes. Int Immunol. 2011;23(8):503–510.
   PubMed Web of Science ®Google Scholar
• Gu W, Shan YA, Zhou J, et al. Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg. 2007;246(1):151–158.
   PubMed Web of Science ®Google Scholar
• Wright CS, Mi LZ, Lee S, et al. Crystal structure analysis of phosphatidylcholine-GM2-activator product complexes: evidence for hydrolase activity. Biochemistry. 2005;44(41):13510–13521.
   PubMed Web of Science ®Google Scholar
• Zhou W, Yuan W, Huang L, et al. Association of neonatal necrotizing enterocolitis with myeloid differentiation-2 and GM2 activator protein genetic polymorphisms. Mol Med Rep. 2015;12(1):974–980.
   PubMed Web of Science ®Google Scholar
• Chertov O, Simpson JT, Biragyn A, et al. Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery. Expert Rev Proteom. 2005;2(1):139–145.
   PubMed Web of Science ®Google Scholar
• Tabuse Y, Nabetani T, Tsugita A. Proteomic analysis of protein expression profiles during Caenorhabditis elegans development using two-dimensional difference gel electrophoresis. Proteomics. 2005;5(11):2876–2891.
   PubMed Web of Science ®Google Scholar
• Jiang P, Siggers JL, Ngai HH, et al. The small intestine proteome is changed in preterm pigs developing necrotizing enterocolitis in response to formula feeding. J Nutr. 2008;138(10):1895–1901.
   PubMed Web of Science ®Google Scholar
• Jiang P, Smith B, Qvist N, et al. Intestinal proteome changes during infant necrotizing enterocolitis. Pediatr Res. 2013;73(3):268–276.
   PubMed Web of Science ®Google Scholar
• Sharpe CR, Sidoli A, Shelley CS, et al. Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance. Nucleic Acids Res. 1984;12(9):3917–3932.
   PubMed Web of Science ®Google Scholar
• Goldberg IJ, Scheraldi CA, Yacoub LK, et al. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem. 1990;265(8):4266–4272.
   PubMed Web of Science ®Google Scholar
• Rovamo L, Nikkilä EA, Taskinen MR, et al. Postheparin plasma lipoprotein and hepatic lipases in preterm neonates. Pediatr Res. 1984;18(11):1104–1107.
   PubMed Web of Science ®Google Scholar
• Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest. 2010;120(8):2989–3000.
   PubMed Web of Science ®Google Scholar
• Sylvester KG, Ling XB, Liu GY, et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr. 2014;164(3):607–12.e1
   PubMed Web of Science ®Google Scholar
• Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005;38(12):1543–1552.
   PubMed Web of Science ®Google Scholar
• Crystal RG. The alpha 1-antitrypsin gene and its deficiency states. Trends Genet. 1989;5(12):411–417.
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Ye D, Dokladny K, et al. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol. 2008;180(8):5653–5661.
   PubMed Web of Science ®Google Scholar
• Murgas Torrazza R, Li N, Young C, et al. Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology. 2013;104(3):234–242.
   PubMed Web of Science ®Google Scholar
• Dessì A, Pintus R, Marras S, et al. Metabolomics in necrotizing enterocolitis: the state of the art. Expert Rev Mol Diagn. 2016;16(10):1053–1058.
   PubMed Web of Science ®Google Scholar
• Wilcock A, Begley P, Stevens A, et al. The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study. J Matern Fetal Neonatal Med. 2016;29(5):758–762.
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Nelson A, Treumann A, et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis. Pediatr Res. 2016;79(3):425–431.
   PubMed Web of Science ®Google Scholar
• Terrin G, Stronati L, Cucchiara S, et al. Serum markers of necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr. Forthcoming. [cited 2017 Apr 5]. DOI:10.1097/MPG.0000000000001588
   Web of Science ®Google Scholar
• Gordon PV, Swanson JR, Attridge JT, et al. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell’s criteria? J Perinatol. 2007;27(11):661–671.
   PubMed Web of Science ®Google Scholar